Intraductal carcinoma of the prostate (IDCP) occurs more commonly in tumors that harbor a germline BRCA2 mutation than in sporadic prostate cancers, and likewise confers a higher risk of mortality7. The gene discussed is BRCA2; the disease is Familial prostate cancer.